Department of General Practice, Univ Rennes, Rennes, France.
Univ Rennes, CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes), Rennes, France.
BMJ Open. 2022 Jul 20;12(7):e045671. doi: 10.1136/bmjopen-2020-045671.
To measure medical students' exposure to pharmaceutical product promotion and incentives nationwide, and to evaluate students' attitudes towards the pharmaceutical industry, access to education on promotional strategies and knowledge of institutional policies about drug company-student relationships.
Cross-sectional survey based on a 48-item anonymous questionnaire.
All 37 French medical schools, from March to April 2019.
French medical students in their 4th year of study and beyond, having studied exclusively in France.
Cumulative frequency of students' exposure to pharmaceutical product promotion and incentives.
Exposure within the last 6 months, attitudes regarding interactions with the industry, access to education on pharmaceutical product promotion and incentives and knowledge of institutional policies.
6280 responses were analysed (10.4% out of a total of 60 550 eligible students). 5992 students (96.3% poststratification, 99% CI (96.1% to 96.5%)) had already been exposed to pharmaceutical product promotion and incentives and 4650 (78.1%, 99% CI (77.7% to 78.6%)) within the last 6 months. 5140 students (85.4%, 99% CI (84.8% to 85.8%)) had met a pharmaceutical representative. Regarding attitudes, 2195 students (36.8%, 99% CI (36.0% to 37.5%)) thought receiving a gift could influence their own prescriptions while 3252 (53.6%, 99% CI (53.1% to 54.2%)) thought it could influence their colleagues' prescriptions. 4533 students (76.0%, 99% CI (75.6% to 76.5%)) reported never having attended any lecture on promotional strategies. Exposure seemed to depend on the year of study and specialty. 5122 (88.1%, 99% CI (87.7% to 88.4%)) did not know whether their faculty had a policy regarding drug company-student interactions.
In France in 2019, medical students' exposure to pharmaceutical product promotion and incentives remains considerable and starts early during medical training. Education on promotional strategies and institutional policies should be improved to ensure responsible and ethical behaviour in prescribing medications.
衡量全国医学生接触药品促销和激励措施的情况，并评估学生对制药行业的态度、获取促销策略教育以及了解机构关于药企与学生关系政策的情况。
基于 48 项匿名问卷的横断面调查。
2019 年 3 月至 4 月期间法国的 37 所医学院校。
在法国完成学业的四年级及以上的法国医学生。
学生接触药品促销和激励措施的累积频率。
过去 6 个月内的接触情况、与行业互动的态度、获取药品促销和激励措施教育以及了解机构政策的情况。
共分析了 6280 名学生的回应（占符合条件的 60550 名学生的 10.4%）。5992 名学生（96.3%的事后分层，99%置信区间（96.1%至 96.5%））已经接触过药品促销和激励措施，4650 名学生（78.1%，99%置信区间（77.7%至 78.6%））在过去 6 个月内接触过。5140 名学生（85.4%，99%置信区间（84.8%至 85.8%））见过药品代表。关于态度，2195 名学生（36.8%，99%置信区间（36.0%至 37.5%））认为收到礼物可能会影响他们自己的处方，而 3252 名学生（53.6%，99%置信区间（53.1%至 54.2%））认为这可能会影响他们同事的处方。4533 名学生（76.0%，99%置信区间（75.6%至 76.5%））报告从未参加过任何关于促销策略的讲座。接触情况似乎取决于学习年限和专业。5122 名学生（88.1%，99%置信区间（87.7%至 88.4%））不知道他们的学院是否有关于药企与学生互动的政策。
2019 年在法国，医学生接触药品促销和激励措施的情况仍然相当可观，并且在医学培训早期就开始了。应加强促销策略和机构政策方面的教育，以确保在开处方方面的负责任和合乎道德的行为。
